Bispecific Antibodies in Oncology Trials: Design and Challenges
Bispecific Antibodies in Oncology Trials: Design and Challenges Designing and Managing Clinical Trials for Bispecific Antibodies in Oncology Introduction to Bispecific Antibodies in Oncology Bispecific antibodies (BsAbs) are engineered to recognize two different antigens or epitopes simultaneously, offering unique mechanisms of action such as redirecting T cells to tumor cells or blocking multiple signaling pathways….
Read More “Bispecific Antibodies in Oncology Trials: Design and Challenges” »